Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Hassleholm – page 2

22 clinical trials in Hassleholm, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Hassleholm at a glance
22
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

22 trials in Hassleholm

Open in trial search

Colitis ulcerative+1

Not yet recruiting

Study of risankizumab plus anti‑α4β7 integrin antibody versus each alone in adults with moderately to severely active Crohn’s disease or ulcerative colitis

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Hip arthroplasty+1

Not yet recruiting

Comparing remifentanil, propofol, bupivacaine, sufentanil, and fentanyl for patients undergoing outpatient total knee and hip replacement surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Epinephrine
  • Sponsor:Region Oerebro Laen

Systemic lupus erythematosus+6

Not yet recruiting

Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:GSKVx000000017064
  • Sponsor:Region Skane

Ischaemic stroke

Not yet recruiting

Study on Imatinib for Improving Recovery in Patients with Acute Ischemic Stroke

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Karolinska Institutet

Giant cell arteritis

Not recruiting

Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Novartis Pharma AG

Facial paresis

Not recruiting

Study on Betamethasone Sodium Phosphate for Treating Acute Facial Nerve Palsy in Children

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Sponsor:Region Dalarna

Breast cancer

Not recruiting

Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane

Study on the Effects of Metoprolol Tartrate for Patients with Chronic Obstructive Pulmonary Disease (COPD) Without Cardiovascular Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Metoprolol Tartrate
  • Sponsor:Region Oerebro Laen

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Ixekizumab
  • Sponsor:NU Hospital Group-Vaestra Goetalandsregionen

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Hassleholm

What the registry says about research in the country

01 Neurovascular Research

Groundbreaking research focusing on acute ischemic stroke treatments, evaluating the effectiveness of novel therapeutic approaches using imatinib administered within critical early hours after stroke onset.

  • Acute Stroke Management
  • Early Intervention Protocols
  • Functional Recovery Assessment

Studies aim to improve patient outcomes through targeted early intervention strategies.

02 Orthopedic Innovation

Clinical investigations exploring innovative approaches to prevent prosthetic joint infections through the use of antibiotic-impregnated bone grafts during hip replacement procedures.

  • Infection Prevention
  • Joint Replacement Technology
  • Surgical Outcomes

Research focuses on enhancing the safety and success rates of hip arthroplasty procedures.

03 Emergency Medicine

Critical research examining the efficacy of Tranexamic acid in treating spontaneous intracerebral hemorrhage, with a particular focus on reducing early mortality in stroke patients.

  • Hemorrhagic Stroke Treatment
  • Emergency Interventions
  • Mortality Prevention

Studies are designed to establish new standards in acute stroke care and emergency medicine protocols.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.